85 related articles for article (PubMed ID: 15774806)
1. Thymidylate synthase expression in colorectal cancer: the never-ending story.
Vincenzi B; Santini D; Tonini G
J Clin Oncol; 2005 Mar; 23(9):2108; author reply 2108-9. PubMed ID: 15774806
[No Abstract] [Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer biology: clinical implications.
Johnston PG; Allegra CJ
Semin Oncol; 1995 Oct; 22(5):418-32. PubMed ID: 7570055
[No Abstract] [Full Text] [Related]
4. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase inhibitors in colorectal cancer.
Cassidy J
Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
[No Abstract] [Full Text] [Related]
6. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil.
Fernández-Contreras ME; Sánchez-Prudencio S; Sánchez-Hernández JJ; García de Paredes ML; Gisbert JP; Roda-Navarro P; Gamallo C
Int J Oncol; 2006 May; 28(5):1303-10. PubMed ID: 16596248
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase in nodal metastases: prognostic for chemosensitivity but not for adjuvant therapy?
Ahlgren JD
J Clin Oncol; 2005 Aug; 23(24):5452-4. PubMed ID: 16009953
[No Abstract] [Full Text] [Related]
9. Clinical colorectal cancer: thymidylate synthase as a molecular biomarker.
Chu E
Clin Colorectal Cancer; 2001 Nov; 1(3):136-7. PubMed ID: 12450424
[No Abstract] [Full Text] [Related]
10. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.
Wilson RH
Oncologist; 2006 Oct; 11(9):1018-24. PubMed ID: 17030644
[TBL] [Abstract][Full Text] [Related]
12. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue.
Zimovjanova M; Sykora V; Novotny J; Gatek J; Petruzelka L; Holubec L; Pecen L
Neoplasma; 2005; 52(3):208-10. PubMed ID: 15875081
[TBL] [Abstract][Full Text] [Related]
16. Cancer chronotherapy: principles, applications, and perspectives.
Vincenzi B; Santini D; La Cesa A; Tonini G
Cancer; 2003 Aug; 98(4):881-2; author reply 882-3. PubMed ID: 12910534
[No Abstract] [Full Text] [Related]
17. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
18. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
[TBL] [Abstract][Full Text] [Related]
19. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
Okumura K; Mekata E; Shiomi H; Naitoh H; Abe H; Endo Y; Kurumi Y; Tani T
Cancer Chemother Pharmacol; 2008 Apr; 61(4):587-94. PubMed ID: 17520254
[TBL] [Abstract][Full Text] [Related]
20. Combination of O6-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy.
Nakajima TE; Yamada Y; Shimoda T; Matsubara J; Kato K; Hamaguchi T; Shimada Y; Okayama Y; Oka T; Shirao K
Eur J Cancer; 2008 Feb; 44(3):400-7. PubMed ID: 18068349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
